How much does generic Selenixol cost in Laos?

Selinexor (Selinexor) is an oral anticancer drug that belongs to a new class of therapeutic drugs called selective nucleocytoplasmic transport inhibitors (Selective Inhibitors of Nuclear Export, SINE). Its unique pharmacological mechanism allows it to show potential efficacy in the treatment of some hematological malignancies, especially multiple myeloma (MM).

Seleniso is already on the market in China and has been included in medical insurance, but its price is quite expensive, about 10,000 to 20,000 yuan, making patients bear higher treatment costs. It is recommended to consult the local hospital pharmacy for specific prices and medical insurance reimbursement status. Different from the domestic market, Seleniso has two options: original drug and generic drug in the foreign market. The original drug is the American version of the original drug. Because of its higher research and development costs, the price is even more expensive, even as high as hundreds of thousands of yuan.

In comparison, generic drugs are more affordable. Lao generic drugs are one of the relatively low-priced generic drugs, with prices ranging from 2,000 yuan to 4,000 yuan. Compared with original drugs, they are more affordable. The ingredients of original drugs and generic drugs are basically the same.

The mechanism of action of this drug is mainly achieved by inhibiting the function of the nucleocytoplasmic transport protein XPO1 (Exportin 1). XPO1Plays a key role in cells transporting proteins from the nucleus to the cytoplasm. In cancer cells, the abnormal activity of XPO1 can lead to abnormal phenomena such as inhibiting the function of tumor suppressor genes and enhancing the expression of tumor-promoting genes.

Selinesol is unique in that it selectively interferes with the function ofXPO1, thereby changing the intracellular localization of some key proteins. This includes some key proteins that regulate the cell cycle, promote cell apoptosis and inhibit tumor growth, such as p53, p21, p27, etc. In this way, selinesol affects tumor cell proliferation and survival.

Selinesol's application scope is mainly focused on the treatment of multiple myeloma, a hematological malignancy caused by the abnormal proliferation of malignant plasma cells in the bone marrow. This drug is often used as part of a combination therapy, along with other chemotherapy drugs or targeted therapies, to increase the effectiveness of the treatment.